IDentification of helper T cell epitopes of dengue virus E-protein
Molecular Immunology, ISSN: 0161-5890, Vol: 30, Issue: 7, Page: 613-625
1993
- 31Citations
- 23Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations31
- Citation Indexes29
- 29
- CrossRef23
- Policy Citations2
- 2
- Captures23
- Readers23
- 23
Article Description
The T cell proliferative response to dengue 2 (Jamaica) E-glycoprotein (495 amino acids) was analyzed in vitro using either killed virus or E-protein fragments or synthetic peptides. Inactivated dengue virus stimulated dengue-specific lymph node (LN) CD4 + T cell proliferation in BALB/c (H-2 d ), C3H (H-2 k ) and DBA/1 (H-2 q ) but not in C57BL/6 (H-2 b ) mice. Moreover, LN cells from dengue-virus primed BALB/c mice proliferated in vitro in response to three purified non-overlapping E-protein fragments expressed in E. coli as polypeptides fused to trpE (f22–205, f267–354, f366–424). To further determine T cell epitopes in the E-protein, synthetic peptides were selected using prediction algorithms for T cell epitopes. Highest proliferative responses were obtained after in vitro exposure of virus-primed LN cells to peptides p135–157, p270–298, p295–307 and p337–359. Peptide p59–78 was able to induce specific B and T cell responses in peptide-primed mice of H-2 d, H-2 q and H-2 k haplotypes. Two peptides p59–78 corresponding to two dengue (Jamaica and Sri Lanka) isolates and differing only at position 71 cross-reacted at the B but not at the T cell level in H-2 b mice. This analysis of murine T helper cell response to dengue E-protein may be of use in dengue subunit vaccine design.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/016158909390072J; http://dx.doi.org/10.1016/0161-5890(93)90072-j; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0027312216&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/7683752; https://linkinghub.elsevier.com/retrieve/pii/016158909390072J; http://linkinghub.elsevier.com/retrieve/pii/016158909390072J; http://api.elsevier.com/content/article/PII:016158909390072J?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:016158909390072J?httpAccept=text/plain; http://dx.doi.org/10.1016/0161-5890%2893%2990072-j; https://dx.doi.org/10.1016/0161-5890%2893%2990072-j
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know